TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial July 25, 2014